TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
-20.71%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$584M
AUM Growth
+$584M
(-21%)
Cap. Flow
+$9.83M
Cap. Flow
% of AUM
1.68%
Top 10 Holdings %
Top 10 Hldgs %
99.8%
Holding
12
New
2
Increased
1
Reduced
3
Closed
–
Top Buys
| 1 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$11.7M |
| 2 |
NCNA
NuCana
NCNA
|
$3.62M |
| 3 |
Prothena Corp
PRTA
|
$784K |
Top Sells
| 1 |
Heron Therapeutics
HRTX
|
$4.26M |
| 2 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$1.14M |
| 3 |
Cellectar Biosciences
CLRB
|
$888K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ODT
1
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $366M | 62.68% | 14,075,269 | – | – |
|
|
2
Heron Therapeutics
HRTX
$207M
| $102M | 17.45% | 5,514,096 -230,000 | -4% | -$4.26M |
|
|
LJPC
3
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $43.5M | 7.44% | 4,938,893 | – | – |
|
4
Rocket Pharmaceuticals
RCKT
$354M
| $34.5M | 5.91% | 2,965,485 | – | – |
|
|
TECX
5
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $11.7M | 2% | +829,121 | New | +$11.7M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $11.1M | 1.9% | 111,844 | – | – |
|
7
Puma Biotechnology
PBYI
$254M
| $3.76M | 0.64% | 349,400 | – | – |
|
|
NCNA
8
NuCana
NCNA
$6.09M
| $3.62M | 0.62% | +500,000 | New | +$3.62M |
|
|
GTHX
9
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $3.42M | 0.58% | 150,000 -50,000 | -25% | -$1.14M |
|
|
10
Prothena Corp
PRTA
$441M
| $3.32M | 0.57% | 423,823 +100,000 | +31% | +$784K |
|
|
ISEE
11
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $672K | 0.12% | 600,000 | – | – |
|
|
12
Cellectar Biosciences
CLRB
$15.5M
| $471K | 0.08% | 235,701 -444,299 | -65% | -$888K |
|